Core Viewpoint - The company, Sinovac Biotech Ltd., has submitted an application for listing on the Hong Kong Stock Exchange, indicating its intention to expand its presence in the international market [1] Group 1: Company Overview - Sinovac Biotech is an innovative and internationally developed biopharmaceutical company [1] - The company focuses on the research, production, and commercialization of recombinant proteins, antibodies, and targeted delivery therapies [1] Group 2: Strategic Focus - The company strategically concentrates on key therapeutic areas such as oncology and autoimmune diseases, which still have significant unmet clinical needs [1] - Through independent innovation and strategic partnerships, the company has established a differentiated portfolio of marketed products and candidate drugs [1] Group 3: Market Positioning - Sinovac Biotech is continuously advancing treatment solutions that possess clinical and market advantages [1]